title: Clinical and molecular features of a TSH-secreting pituitary microadenoma.
abstract: We describe a case of a thyroid stimulating hormone (TSH)-secreting pituitary microadenoma, and report the systematic gene expression profile of the surgically- removed tumor. A 50-year-old woman was referred to our hospital because she had high TSH, free-T4, and free-T3 levels, and a pituitary tumor that was visualized with magnetic resonance imaging. Her basal TSH level was high even after a high T3 loading dose, and increased following administration of thyroid releasing hormone (TRH) even after administration of a high dose of exogenous T3. Her clinical symptoms and peripheral markers for T3 were responsive to exogenous T3. There was no thyroid hormone receptor (TR) beta gene mutation. The patient was diagnosed with a TSH-secreting pituitary adenoma, and trans-sphenoid surgery was performed. The histologic features and immunophenotype were consistent with a TSH-secreting pituitary adenoma. Reverse transcription-polymerase chain reaction analysis of pituitary hormones, pituitary-specific transcription factors, receptors, and transcriptional cofactors of clinical significance was performed on the removed tumor. The tumor expressed TSH, growth hormone, prolactin, alpha-subunit, pituitary transcription factor-1 (pit-1) but not proopiomelanocortin (POMC), prophet of pit-1 (prop-1) and pituitary cell-restricted T box factor (Tpit). TRbeta and TRH-receptor gene expression was normal. Three steroid receptor coactivators (SRC)-1, SRC-2, and SRC-3 were expressed. Nuclear receptor corepressor (N-CoR)2 was absent in the tumor, whereas nuclear receptor corepressor (N-CoR1) was expressed. Somatostatin receptor type 1 expression was significantly decreased, whereas type 4 receptor was expressed, which are unusual characteristics for pituitary tumors. The gene expression pattern in the tumor might have a role in the clinical features of this case.
authors.affiliation: Department of Endocrinology Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan. tusui@kuhp.kyoto-u.ac.jp
authors.forename: Takeshi
authors.initials: T
authors.lastname: Usui
authors.forename: Shoichiro
authors.initials: S
authors.lastname: Izawa
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Sano
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tagami
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nagata
authors.forename: Akira
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Jun A
authors.initials: JA
authors.lastname: Takahashi
authors.forename: Mitsuhide
authors.initials: M
authors.lastname: Naruse
mesh_terms: D000236:Adenoma / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D016133:Polymerase Chain Reaction; D037042:Thyroid Hormone Receptors beta / Q000096:biosynthesis; D013972:Thyrotropin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone; D014284:Triiodothyronine
chemical_list: D037042:Thyroid Hormone Receptors beta; D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin